The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
104404043 10440404 3 F 20130419 20160707 20140909 20160711 EXP DE-ROCHE-1458222 ROCHE 67.60 YR M Y 95.00000 KG 20160712 MD DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
104404043 10440404 1 PS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) Y 125085 712 MG Q3W
104404043 10440404 2 SS Bevacizumab BEVACIZUMAB 1 Intravenous (not otherwise specified) DATE OF LAST DOSE PRIOR TO EVENT : 03/APR/2013 Y 125085 712 MG Q3W
104404043 10440404 3 C CAPECITABINE. CAPECITABINE 1 Oral 0 4000 MG
104404043 10440404 4 C CAPECITABINE. CAPECITABINE 1 Oral 0 3300 MG
104404043 10440404 5 C CAPECITABINE. CAPECITABINE 1 Oral 0 4000 MG
104404043 10440404 6 C CAPECITABINE. CAPECITABINE 1 Oral 0 3300 MG
104404043 10440404 7 C CAPECITABINE. CAPECITABINE 1 Oral 0 3300 MG
104404043 10440404 8 C CAPECITABINE. CAPECITABINE 1 Oral 0 420 MG
104404043 10440404 9 C CAPECITABINE. CAPECITABINE 1 Oral 0 420 MG
104404043 10440404 10 C CAPECITABINE. CAPECITABINE 1 Oral 0 420 MG
104404043 10440404 11 C CAPECITABINE. CAPECITABINE 1 Oral 0 420 MG
104404043 10440404 12 C CAPECITABINE. CAPECITABINE 1 Oral 0 420 MG
104404043 10440404 13 C CLEXANE ENOXAPARIN SODIUM 1 Subcutaneous 0 .4 ML QOD
104404043 10440404 14 C PANTOPRAZOL PANTOPRAZOLE SODIUM 1 Oral 0 40 MG QOD
104404043 10440404 15 C IRINOTECAN IRINOTECAN 1 Intravenous (not otherwise specified) 0 420 MG
104404043 10440404 16 C IRINOTECAN IRINOTECAN 1 Intravenous (not otherwise specified) 0 420 MG
104404043 10440404 17 C METOPROLOL. METOPROLOL 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
104404043 10440404 1 Colorectal cancer
104404043 10440404 3 Colorectal cancer
104404043 10440404 13 Deep vein thrombosis
104404043 10440404 14 Prophylaxis against gastrointestinal ulcer
104404043 10440404 15 Colorectal cancer
104404043 10440404 17 Hypertension

Outcome of event

Event ID CASEID OUTC COD
104404043 10440404 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
104404043 10440404 Abdominal pain
104404043 10440404 Cystitis haemorrhagic
104404043 10440404 Gastrointestinal haemorrhage
104404043 10440404 Gastrointestinal oedema
104404043 10440404 Haematuria
104404043 10440404 Hypokalaemia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
104404043 10440404 1 20130220 20130220 0
104404043 10440404 2 20130403 20130403 0
104404043 10440404 3 20130109 20130122 0
104404043 10440404 4 20130220 20130305 0
104404043 10440404 5 20130130 20130212 0
104404043 10440404 6 20130314 20130327 0
104404043 10440404 7 20130403 20130416 0
104404043 10440404 8 20130109 20130109 0
104404043 10440404 9 20130130 20130130 0
104404043 10440404 10 20130220 20130220 0
104404043 10440404 11 20130314 20130314 0
104404043 10440404 12 20130403 20130403 0
104404043 10440404 15 20130109 20130403 0
104404043 10440404 16 20120220 0